Additional file 3: of Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy

Figure S2. Human PD1-Fc-OX40L ARC binds via Fc and OX40L domains using ELISA, and to the neonatal receptor FcRn using SPR. (TIF 1003 kb)

Tags
Data and Resources
To access the resources you must log in

This item has no data

Identity

Description: The Identity category includes attributes that support the identification of the resource.

Field Value
PID https://www.doi.org/10.6084/m9.figshare.7483664
PID https://www.doi.org/10.6084/m9.figshare.7483664.v1
URL https://dx.doi.org/10.6084/m9.figshare.7483664.v1
URL https://dx.doi.org/10.6084/m9.figshare.7483664
URL http://dx.doi.org/10.6084/m9.figshare.7483664
URL http://dx.doi.org/10.6084/m9.figshare.7483664.v1
Access Modality

Description: The Access Modality category includes attributes that report the modality of exploitation of the resource.

Field Value
Access Right Open Access
Attribution

Description: Authorships and contributors

Field Value
Author Fromm, George
Author Silva, Suresh De
Author Kellsey Johannes
Author Patel, Arpita
Author Hornblower, Josiah
Author Schreiber, Taylor
Publishing

Description: Attributes about the publishing venue (e.g. journal) and deposit location (e.g. repository)

Field Value
Collected From Datacite; figshare
Hosted By figshare
Publication Date 2018-12-19
Publisher figshare
Additional Info
Field Value
Language Undetermined
Resource Type Dataset; Image
keyword FOS: Chemical sciences
keyword FOS: Health sciences
keyword FOS: Biological sciences
keyword FOS: Clinical medicine
system:type dataset
Management Info
Field Value
Source https://science-innovation-policy.openaire.eu/search/dataset?datasetId=dedup_wf_001::84cffcb08f1496039d74ee6cbf7903b1
Author jsonws_user
Last Updated 14 January 2021, 14:46 (CET)
Created 14 January 2021, 14:46 (CET)